Jane Street Group, LLC Intellia Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 236,127 shares of NTLA stock, worth $3.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

236,127

Previous 245,426 3.79%

Holding current value

$3.57 Million

Previous $5.49 Million 11.65%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $183,376 - $254,420	-9,299 Reduced 3.79%	236,127 $4.85 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $3.03 Million - $4.13 Million	151,594 Added 161.56%	245,426 $5.49 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $2.63 Million - $3.62 Million	-110,453 Reduced 54.07%	93,832 $2.58 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $2.69 Million - $3.76 Million	116,308 Added 132.2%	204,285 $6.23 Million
Q3 2023 Nov 14, 2023	SELL	$31.62 - $45.78 $3.7 Million - $5.35 Million	-116,862 Reduced 57.05%	87,977 $2.78 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $5.42 Million - $7.21 Million	156,638 Added 324.97%	204,839 $8.35 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $426,972 - $574,682	-12,822 Reduced 21.01%	48,201 $1.8 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $999,355 - $1.89 Million	30,092 Added 97.29%	61,023 $2.13 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $491,696 - $653,832	-9,119 Reduced 22.77%	30,931 $1.73 Million
Q2 2022 Aug 16, 2022	BUY	$38.49 - $76.21 $712,180 - $1.41 Million	18,503 Added 85.87%	40,050 $2.07 Million
Q1 2022 May 17, 2022	SELL	$58.27 - $118.99 $778,895 - $1.59 Million	-13,367 Reduced 38.29%	21,547 $1.57 Million
Q4 2021 Feb 15, 2022	BUY	$100.76 - $138.36 $1.53 Million - $2.1 Million	15,153 Added 76.68%	34,914 $4.13 Million
Q3 2021 Nov 16, 2021	SELL	$132.37 - $176.78 $4.23 Million - $5.65 Million	-31,938 Reduced 61.78%	19,761 $2.65 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $400,468 - $1.07 Million	-6,578 Reduced 11.29%	51,699 $8.37 Million
Q1 2021 May 18, 2021	SELL	$46.59 - $83.68 $2.19 Million - $3.94 Million	-47,034 Reduced 44.66%	58,277 $4.68 Million
Q4 2020 Feb 17, 2021	BUY	$18.83 - $63.53 $1.38 Million - $4.67 Million	73,549 Added 231.56%	105,311 $5.73 Million
Q3 2020 Nov 17, 2020	BUY	$17.47 - $24.93 $359,602 - $513,159	20,584 Added 184.15%	31,762 $631,000
Q2 2020 Aug 17, 2020	BUY	$11.14 - $22.87 $124,522 - $255,640	11,178 New	11,178 $235,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.15B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Intellia Therapeutics, Inc. Transaction History